2026 NPPES data Neurology Physician NPI 1396075255 M.D.
Verify on CMS →

Daphne Robakis, M.D.

Neurology Physician in New Haven, Connecticut.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 19,885 in Neurology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
773
Medicare Part D claims · 104 beneficiaries · Neurology Physician avg: 1K
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Daphne Robakis, M.D. filed 773 Medicare Part D claims in 2023 as a Neurology Physician in New Haven, Connecticut, prescribing 83% generic.

773
Part D claims, 2023
83%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Daphne Robakis, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

773 Top 29% higher than 71% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Daphne Robakis, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Daphne Robakis, M.D.?

Quality data not reported

NPI registry status

Active

Issued 12/28/2009

NPI 1396075255

Primary specialty

Neurology Physician

Mid-sized

19,885 US NPIs in this specialty

Medicare Part D claims

773 41% vs specialty avg

2023 prescription claims

Specialty avg: 1,309

Specialty distribution in Connecticut

How Neurology Physician compares to other specialties among Connecticut providers

Connecticut providers
Clinical Social Worker - 8.4%Clinical Social Worker8.4%Student in an Organized Health Care Education/Training Program - 7.7%Student in an Organized Health Care Education/Training Program7.7%Physical Therapist - 4.2%Physical Therapist4.2%Pharmacist - 3.9%Pharmacist3.9%Internal Medicine Physician - 3.4%Internal Medicine Physician3.4%Mental Health Counselor - 3.2%Mental Health Counselor3.2%Neurology Physician - 0.4%Neurology Physician0.4%
Largest specialties in Connecticut (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Neurology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Daphne Robakis, M.D. appears in the CMS NPPES registry as a Neurology Physician provider holding M.D. credentials at 800 HOWARD AVE, New Haven, CT, 06519, with a listed phone of (203) 785-4085. NPI 1396075255 was issued on 12/28/2009.

Medicare Part D records for calendar year 2023 show 773 prescription claims written by this provider, covering 104 Medicare beneficiaries and totaling roughly $215K in drug spend, split 17% brand-name and 83% generic by claim count.

Neurology Physician is a mid-sized specialty nationwide, with 19,885 enrolled providers across 54 states and an average of 1,309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

800 HOWARD AVE
New Haven, CT 06519

Provider Details

NPI 1396075255
Specialty Neurology Physician
Credentials M.D.
Gender Female
NPI Issued 12/28/2009

Brand vs generic prescribing mix · Typical

Daphne Robakis, M.D. - brand share 17.0%
Neurology Physician average

17% brand-name claims vs 83% generic, on 773 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

773
Total Claims
$215K
Total Drug Cost
104
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
995
Total Day Supply
29,410
Brand vs Generic
17% brand / 83% generic
Brand Drug Cost
$143K
Generic Drug Cost
$72K

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
2.01
Gender Split
50% female / 50% male
Age Distribution
<65: 12, 65-74: 37, 75-84: 40, 85+: 15

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Daphne Robakis, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Carbidopa-Levodopa
Carbidopa/Levodopa
211
Rytary
Carbidopa/Levodopa
72
Rasagiline Mesylate
57
Amantadine
Amantadine Hcl
56
Carbidopa-Levodopa Er
Carbidopa/Levodopa
43
Quetiapine Fumarate
35
Selegiline Hcl
31
Gabapentin
28
Sumatriptan Succinate
23
Entacapone
21

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neurology Physician Overview

How Daphne Robakis, M.D. fits within the Neurology Physician landscape nationally.

19,885
Neurology Physician Providers in US
54
States with Neurology Physician
1,309
Avg Claims per Provider

Daphne Robakis, M.D.'s 773 claims are below the specialty average of 1,309.

Nearby Neurology Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Robakis.

Compare Neurology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Connecticut medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Neurology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Daphne Robakis, M.D.'s specialty?
Daphne Robakis, M.D. specializes in Neurology Physician and practices in New Haven, Connecticut. Credentials: M.D..
How much does Daphne Robakis, M.D. prescribe under Medicare Part D?
In 2023, Daphne Robakis, M.D. wrote 773 Medicare Part D claims totaling $215K in drug costs for 104 beneficiaries.
Where is Daphne Robakis, M.D. located?
Daphne Robakis, M.D. is located at 800 HOWARD AVE, New Haven, CT, 06519. Phone: (203) 785-4085.
What is Daphne Robakis, M.D.'s NPI number?
Daphne Robakis, M.D.'s National Provider Identifier (NPI) is 1396075255, issued on 12/28/2009.
Does Daphne Robakis, M.D. prescribe more brand-name or generic drugs?
Daphne Robakis, M.D.'s prescribing is 17% brand-name and 83% generic drugs by claim count, with $143K in brand drug costs.
How many Neurology Physician providers are there in the US?
There are 19,885 Neurology Physician providers across 54 states in the US. The average Neurology Physician provider writes 1,309 Medicare Part D claims per year.
What drugs does Daphne Robakis, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Daphne Robakis, M.D.'s most frequently prescribed drugs include Carbidopa-Levodopa, Rytary, Rasagiline Mesylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daphne Robakis, M.D. accept Medicare?
Daphne Robakis, M.D. appears in CMS Medicare data with 773 Part D claims and 104 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daphne Robakis, M.D.'s credentials?
Daphne Robakis, M.D.'s NPI is 1396075255 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.